HE homepage

Seventeen Republicans joined Democrats to pass a three-year extension to the tax credits that made medical plans sold through HealthCare.gov cheaper for millions of Americans. However, the GOP passed a competing measure in December that would see the federal government focus on association health plans. It’s unclear if either will find traction in the Senate.

The latest federal jobs report brings good news to healthcare and social assistance, bad news to most other sectors.  

AI is an icy landslide sweeping through healthcare. Even surgeons must choose between two stark options: Ride the crest of the powder cloud now or dig yourselves out of a deep runout zone later. 

The U.S. Department of Justice alleges that 52-year-old Ritesh Kalra, MD, wrote 50 prescriptions a day for addictive painkillers and billed New Jersey Medicaid for patient visits that never occurred. The alleged incidents occurred between 2019 and 2025.

Numerous “alternative funding programs” are named as defendants in what is a larger challenge of the right of these third-party organizations to import drugs from overseas, bypassing FDA regulations. 

Philadelphia-based Jefferson Health has accused the three biggest PBMs—Caremark, Express Scripts and Optum Rx—of a de facto collusion scheme involving the primary makers of insulin, Eli Lilly, Novo Nordisk and Sanofi. The lawsuit alleges rebates offered by the manufacturers unfairly burden self-insured and public health plans, like the one the health system uses for its employees.